Your investment journey, step 5: Arriving at your destination
People are living longer, healthier lives than ever. That means planning your income in retirement is important, and investment companies have unique advantages when it comes to smoothing income over time. Remember, income is not guaranteed and your capital is at risk.
Your Investment Journey
Investing for life is like a journey. What will you save for, a first home, your children’s future or perhaps your retirement, and do you need a lump sum, a regular income or a combination of both? Find out how investment companies can help at every stage of your investment journey.
Scottish American: seeking an income that keeps on track
Join Toby Ross and James Dow, Scottish American’s joint managers, on their travels as they seek out the companies from across the globe that they believe can deliver a dependable and growing income along with capital growth.
Baillie Gifford UK Growth Fund: manager update
Milena Mileva and Iain McCombie, co-managers of the Baillie Gifford UK Growth Fund, give an overview of the company following the board’s decision to move the mandate to Baillie Gifford.
Scottish Investment Trust contrarian insights: UK food retail
Manager Alasdair McKinnon gives his contrarian perspective on the UK’s food retail industry, an area of the market he believes offers attractive investment opportunities.
City of London: webinar
City of London fund manager Job Curtis tackles investor questions with financial journalist Cherry Reynard. He addresses concerns around a so-called ‘hard Brexit’ and possible implications for the company’s portfolio.
Alliance Trust stock spotlight: Oerlikon & Henry Schei
Bill Kanko, Founder and President of Black Creek Investment Management, discusses why Alliance Trust saw value in industrial group Oerlikon and healthcare distributor Henry Schein.
An introduction to Martin Currie Asia Unconstrained Trust
Andrew Graham, Portfolio Manager, explains why Asia could offer a compelling opportunity for investors.
Biotech Growth: Fund Manager update
Portfolio Manager, Geoffrey Hsu, discusses why innovation in areas such as gene therapy is presenting exciting opportunities in the biotechnology sector.